Do you feel taking medication several times daily for spasticity is controlling you?
If you or someone you know has spasticity due to Multiple Sclerosis (MS)
they may be able to qualify for this research study.
This clinical study is currently evaluating the safety and effectiveness of an investigational oral medication that is similar to a currently approved medication, baclofen. The study medication is being evaluated to determine whether an extended release (ER) medication is effective at treating spasticity with once daily dosing after your evening meal.
The trial is currently enrolling participants at across the United States. Approximately 300 men and women who suffer from spasticity due to MS are expected to participate in the trial. Your participation will last approximately 23 weeks.
To qualify or learn more about this study.
Call CCRstudies @ (860) 443-4567
Dr. Laurence Radin of Neurological Group, PC is conducting this study.
No insurance is needed.
Your study medications, study-related exams and lab testing will be at no cost.